Retraction Note: Glycogen synthase kinase-3β inhibition attenuates the development of ischaemia/reperfusion injury of the gut (Intensive Care Medicine, (2007), 33, 5, (880-893), 10.1007/s00134-007-0595-1);Glycogen synthase kinase-3β inhibition attenuates the development of ischaemia/reperfusion injury of the gut

Intensive Care Medicine

Volumn 33, Issue 5, 2007, Pages 880-893

  Cuzzocrea, Salvatore ^a,b   Mazzon, Emanuela ^a,b   Esposito, Emanuela ^c   Muià, Carmelo ^a   Abdelrahman, Maha ^d   Di Paola, Rosanna ^a,b   Crisafulli, Concetta ^a   Bramanti, Placido ^b   Thiemermann, Christoph ^d  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

4 Benzyl 2 methyl 1,2,4 thiadiazolidine 3,5 dione; Adhesion molecules; Cytokines; Ischaemia reperfusion; Myeloperoxidase; Nitrotyrosine

Indexed keywords

1,2,4 THIADIAZOLE DERIVATIVE; 3 NITROTYROSINE; 4 BENZYL 2 METHYL 1,2,4 THIADIAZOLIDINE 3,5 DIONE; GLYCOGEN SYNTHASE KINASE 3BETA; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MYELOPEROXIDASE; PADGEM PROTEIN; PHOSPHOTRANSFERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTERY OCCLUSION; ARTICLE; CELIAC ARTERY STENOSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG POTENCY; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; HISTOPATHOLOGY; IMMUNOREACTIVITY; INTESTINE INJURY; INTESTINE ISCHEMIA; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION; REPERFUSION INJURY; SHOCK; SPLANCHNIC BLOOD FLOW; SUPERIOR MESENTERIC ARTERY OBSTRUCTION; SURVIVAL;

EID: 34247596072     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-024-07320-y     Document Type: Erratum

References (36)

1. Di Paola R, Muia C, Mazzon E, Genovese T, Crisafulli C, Menegazzi M, Caputi AP, Suzuki H, Cuzzocrea S (2005) Effects of hypericum perforatum extract in a rat model of ischemia and reperfusion injury. Shock 24:255-263
2. Lefer AM, Lefer DJ (1993) Pharmacology of the endothelium in ischaemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol 33:71-90
3. Butcher EC (1992) Leukocyte-endothelial cell adhesion as an active, multi-step process: a combinatorial mechanism for specificity and diversity in leukocyte targeting. Adv Exp Med Biol 323:181-194
4. Hubbard AK, Rothlein R (2000) Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med 28:1379-1386
5. Van Wauwe J, Haefner B (2003) Glycogen synthase kinase-3 as drug target: from wallflower to center of attention. Drug News Perspect 16:557-565
6. Woodgett JR (2001) Judging a protein by more than its name: GSK-3. Sci STKE 100:RE12
7. Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Roxbee Cox L, Mills D, Brown MJ, Haigh D, Ward RW, Smith DG, Murray KJ, Reith AD, Holder JC (2000) Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol 7:793-803
8. Ali A, Hoeflich KP, Woodgett JR (2001) Glycogen synthase kinase-3: properties, functions and regulation. Chem Rev 101:2527-2540
9. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR (2000) Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406:86-90
10. Takada Y, Fang X, Jamaluddin MS, Boyd DD, Aggarwal BB (2004) Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. J Biol Chem 279:39541-39554
11. Dugo L, Collin M, Allen DA, Patel NS, Bauer I, Mervaala EM, Louhelainen M, Foster SJ, Yaqoob MM, Thiemermann C (2005) GSK-3 beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat. Crit Care Med 33:1903-1912
12. Martin M, Rehani K, Jope RS, Michalek SM (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6:777-784
13. Whittle BJR, Varga C, Pòsa A, Molnar A, Collin M, Thiemermann C (2006) Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3β. Br J Pharmacol 147:575-582
14. Cuzzocrea S, Genovese T, Mazzon E, Crisafulli C, Di Paola R, Muia C, Collin M, Esposito E, Bramanti P, Thiemermann C (2006) Glycogen synthase kinase-3{beta} inhibition reduces secondary damage in experimental spinal cord trauma. J Pharmacol Exp Ther 318:79-89
15. Caputi AP, Rossi F, Carney K, Brezenoff HE (1980) Modulatory effect of brain acetylcholine on reflex-induced bradycardia and tachycardia in conscious rats. J Pharmacol Exp Ther 215:309-316
16. Hayward R, Lefer AM (1998) Time course of endothelial-neutrophil interaction in splanchnic artery ischaemia-reperfusion Am J Physiol 275:2080-2086
17. Dugo L, Collin M, Allen DA, Patel NS, Bauer I, Mervaala EM, Louhelainen M, Foster SJ, Yaqoob MM, Thiemermann C (2005) GSK-3 beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat. Crit Care Med 33:1903-1912
18. Cuzzocrea S, Mazzon E, Di Paola R, Muià C, Crisafulli C, Dugo L, Collin M, Britti D, Caputi AP, Thiemermann C (2006) Glycogen synthase kinase-3β inhibition attenuate the degree of arthritis caused by type II collagen in the mouse. Clinical Immunology 120:57-67
19. Cuzzocrea S, Crisafulli C, Mazzon E, Esposito E, Muia C, Abdelrahman M, Di Paola R, Thiemermann C (2006) Inhibition of glycogen synthase kinase-3beta attenuates the development of carrageenan-induced lung injury in mice. Br J Pharmacol 149:687-702
20. Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muia C, Centorrino T, Caputi AP (2004) Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-alpha) in the development of inflammatory bowel disease in mice. Lab Invest 84:1643-1654
21. Mullane KM, Kraemer R, Smith B (1985) Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14:157-167
22. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 92:351-358
23. Cuzzocrea S, Sautebin L, De Sarro G, Costantino G, Rombola L, Mazzon E, Ialenti A, De Sarro A, Ciliberto G, Di Rosa M, Caputi AP, Thiemermann C (1999) Role of IL-6 in the pleurisy and lung injury caused by carrageenan. J Immunol 163:5094-5104
24. Albert CJ, Ford DA (1998) Identification of specific nuclear protein kinase C isozymes and accelerated protein kinase C-dependent nuclear protein phosphorylation during myopcardial ischemia. FEBS Lett 438:32-36
25. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D (2001) Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 53:135-159
26. Verma IM (2004) Nuclear factor (NF)-kappaB proteins: therapeutic targets. Ann Rheum Dis 2:57-61
27. Cuzzocrea S (2004) Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injury. Vascul Pharmacol 41:187-195
28. Salvemini D, Muscoli C, Riley DP, Cuzzocrea S (2002) Superoxide dismutase mimetics. Pulm Pharmacol Ther 15:439-447
29. Cuzzocrea S, Costantino G, Mazzon E, Micali A, De Sarro A, Caputi AP (2000) Beneficial effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion. J Pineal Res 28:52-63
30. Romeo C, Antonuccio P, Esposito M, Marini H, Impellizzeri P, Turiaco N, Altavilla D, Bitto A, Zuccarello B, Squadrito F (2004) Raxofelast, a hydrophilic vitamin e-like antioxidant, reduces testicular ischemia-reperfusion injury. Urol Res 32:367-371
31. Cuzzocrea S, Mazzon E, Dugo L, Caputi AP, Aston K, Riley DP, Salvemini D (2001) Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion. Br J Pharmacol 132:19-29
32. Misko TP, Costantino G, Mazzon E, Micali A, Caputi AP, Macarthur H, Salvemini D (2000) Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. FASEB J 14:1061-1072
33. Pap M, Cooper GM (1998) Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 273:19929-19932
34. Bournat JC, Brown AM, Soler AP (2000) Wnt-1 dependent activation of the survival factor NF-kB in PC12 cells. J Neurosci Res 61:21-32
35. Ozes ON, Mayo LD, Gustin JA et al (1999) NF-kB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401:82-85
36. Carbott DE, Duan L, Davis MA (2002) Phosphoinositol 3 kinase inhibitor, LY294002 increases bcl-2 protein and inhibits okadaic acid-induced apoptosis in Bcl-2 expressing renal epithelial cells. Apoptosis 7:69-76